Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
George Church
Biotech
Merck bets up to $1B on Pearl's 'smart' biologics
Pearl Bio has signed onto a major licensing deal with Merck while raising its own series A round.
Max Bayer
Mar 12, 2024 8:00am
George Church-founded biotech tacks on $40M series A
Jul 14, 2022 8:00am
LetsGetChecked adds genetic sequencing to at-home testing slate
Mar 29, 2022 6:00am
Harvard's Nabla Bio nabs $11M for AI-driven antibody design
Dec 7, 2021 9:34am
Church is auctioning off his genome as an NFT
Apr 20, 2021 10:25am
Rejuvenate Bio banks $10M to advance gene therapy for aging
Apr 19, 2021 11:00am